Our ESR12 defended her Doctoral Thesis: Evaluation of genetic polymorphisms associated with the metabolic effects of olanzapine and aripiprazole
17 December, 2020 · No Comments
Read More
Ángela M. Valverde, coordinator of ITN TREATMENT and member of CIBERDEM, took part in the videoconference organized by MSD (Merck Sharp & Dohme) and CIBERDEM (spanish network of diabetes and metabolic diseases) as moderator
Read MoreTREATMENT Mid-Term Review TREATMENT School 2: The epidemic of fatty liver diseases: risk factors, treatment and extrahepatic consequences 20th November, 2018 Session I: TREATMENT Mid-Term Review (Part I) 9:00-9:15 Short introduction by the REA Project Officer, the External expert and […]
Read MoreÁngela M. Valverde, coordinator of ITN TREATMENT, attended the Annual Conference of ciderdem, 2018. Dr. Valverde and her team showed the latest results of their investigations. You can find more information in the following link.
Read More